Urinary tract infections caused by Pseudomonas aeruginosa: a minireview.

Division of Infectious Diseases, Childrens Hospital Los Angeles, Los Angeles, CA 90027, USA.
Journal of infection and public health 01/2009; 2(3):101-11. DOI: 10.1016/j.jiph.2009.08.003
Source: PubMed

ABSTRACT Urinary tract infections (UTIs) are a serious health problem affecting millions of people each year. Infections of the urinary tract are the second most common type of infection in the body. Catheterization of the urinary tract is the most common factor, which predisposes the host to these infections. Catheter-associated UTI (CAUTI) is responsible for 40% of nosocomial infections, making it the most common cause of nosocomial infection. CAUTI accounts for more than 1 million cases in hospitals and nursing homes annually and often involve uropathogens other than Escherichia coli. While the epidemiology and pathogenic mechanisms of uropathogenic Escherichia coli have been extensively studied, little is known about the pathogenesis of UTIs caused by other organisms like Pseudomonas aeruginosa. Scanty available information regarding pathogenesis of UTIs caused by P. aeruginosa is an important bottleneck in developing effective preventive approaches. The aim of this review is to summarize some of the advances made in the field of P. aeruginosa induced UTIs and draws attention of the workers that more basic research at the level of pathogenesis is needed so that novel strategies can be designed.

1 Bookmark
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The successes of modern medicine are intimately connected to the ever-increasing use of biomedical devices such as those used for vital functions management. Catheters of different types are the most common assist devices utilized every year. Current materials from which such medical devices are made include polyurethane, Teflon®, silicone rubber, polyethylene, polypropylene, polyvinyl chloride, and polytetrafluoroethylene. After exposure to body fluids the device becomes an environment suitable to support biofilm growth and subsequent infection. Even today, the treatment of choice for patients with infected devices is the catheter removal. Bacterial biofilms cause chronic infections due to the increased tolerance to antibiotics and disinfectants, resistance to phagocytosis and to the human defence system. Depending on the type and composition of the medical device, some pathogens are more prevalent. Staphylococcus aureus, S. epidermidis, Escherichia coli and Pseudomonas aeruginosa are the microorganisms most frequently involved in catheter-related infections.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In the human pathogen Pseudomonas aeruginosa, the GltR regulator is required for glucose transport, whereas GtrS is a sensor kinase that plays a key role in mediating bacteria-host interaction and pathogen dissemination in the host. We show that GtrS and GltR form a two-component system that regulates the expression from the promoters Pedd/gap-1, PoprB and Pglk, which control the expression of genes involved in glucose metabolism and transport. In addition, the GtrS/GltR pair regulates the expression of toxA that encodes exotoxin A, the primary virulence factor. Microcalorimetry-based ligand screening of the recombinant GtrS ligand-binding domain revealed specific binding of 2-ketogluconate (2-KG) (KD = 5 μM) and 6-phosphogluconate (KD = 98 μM). These effectors accelerate GtrS autophosphorylation, with concomitant transphosphorylation of GltR leading to a three-fold increase in transcription. Surprisingly, in vivo a similar increase in expression from the above promoters was observed for the mutant deficient in GltR regardless of the presence of effectors. The GltR operator site was found to contain the consensus sequence 5'-tgGTTTTTc-3'. We propose that 2-KG is a key metabolite in the stringent transcriptional control of genes involved in virulence and glucose metabolism. We show that GltR is a transcriptional repressor that is released from DNA upon phosphorylation.
    Nucleic Acids Research 06/2014; · 8.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: First report of prevention of UTIs by flagellin.•Flagellin without any adjuvant afforded good protection.•Activates both non-specific and specific (active and passive) immunities.•Reverted structural integrity of kidney tissue to near normal by reducing inflammation and clearing bacterial load.
    Immunology Letters 10/2014; · 2.37 Impact Factor

Full-text (2 Sources)

Available from
May 29, 2014